Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedApr 1, 2015AIR COMPRESSEDFailed Impurities/Degradation Specification; out of specification results for carbon dioxideMatheson, Inc. · D-0423-2015Class IITerminatedApr 1, 2015Haloperidol Decanoate InjectionLack of Assurance of Sterility; due to leaking vialsMylan Institutional LLC · D-0422-2015Class IITerminatedApr 1, 2015Haloperidol Decanoate InjectionLack of Assurance of Sterility; due to leaking vialsMylan Institutional LLC · D-0421-2015Class IIITerminatedApr 1, 2015Fentanyl Citrate InjFailed Impurities/Degradation Specifications; 12 month stability testing.West-Ward Pharmaceutical Corporation · D-0420-2015Class IITerminatedMar 25, 2015Antacid Liquid Regular Strength Antacid & Anti-GasMicrobial Contamination of Non-Sterile Products: Lots failed microbiological testing at the 12-month time point.Tarmac Products, Inc. · D-0419-2015Class IITerminatedMar 25, 20155% DEXTROSE InjectionLack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container.Hospira Inc. · D-0417-2015Class IITerminatedMar 25, 2015RIFAMPIN for InjectionLack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.Heritage Pharmaceuticals, Inc. · D-0416-2015Class IITerminatedMar 25, 2015Colistimethate for Injection USPLack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.Heritage Pharmaceuticals, Inc. · D-0415-2015Class IITerminatedMar 25, 2015Ergoloid MesylatesFailed Impurities/Degradation Specifications: during long-term stability testing.Mutual Pharmaceutical Company, Inc. · D-0414-2015Class IIITerminatedMar 25, 2015Nicardipine Hydrochloride InjectionSubpotent Drug and Failed Impurities/Degradation SpecificationsMylan Institutional LLC · D-0413-2015Class IIITerminatedMar 25, 2015DOXOrubicin Hydrochloride InjectionCorrect Labeled Product Mispack: Ifosfamide Injection 50 mg/mL, 60 mL, correctly labeled vial may have been mis-packaged in a carton labeled Doxorubicin Hydrochloride...Mylan Institutional LLC · D-0412-2015Class IITerminatedMar 18, 2015PROMETHAZINE DM SYRUPPresence of Foriegn Substance: Plastic cap closure particulates may be present in the product.Qualitest Pharmaceuticals · D-0411-2015Class IITerminatedMar 18, 2015DICOPANOLMicrobial Contamination of a Non-Sterile Product: Kit component is contaminated with Burkholderia multivorans.Fusion Pharmaceuticals, LLC · D-0410-2015Class IIITerminatedMar 18, 2015Simvastatin TabletsFailed Impurities/Degradation Specifications: Product failed a known impurity specification.Micro Labs Usa, Inc S · D-0409-2015Class IIITerminatedMar 18, 2015Simvastatin TabletsFailed Impurities/Degradation Specifications: Product failed a known impurity specification.Micro Labs Usa, Inc S · D-0408-2015Class IIITerminatedMar 18, 2015Simvastatin TabletsFailed Impurities/Degradation Specifications: Product failed a known impurity specification.Micro Labs Usa, Inc S · D-0407-2015Class IITerminatedMar 11, 2015Vancomycin Hydrochloride CapsulesSubpotent DrugActavis Inc · D-0406-2015Class IITerminatedMar 11, 2015Fluticasone Propionate Nasal SprayFailed Stability Specifications: Out of specification for preservative, benazalkonium chloride.Akorn, Inc. · D-0405-2015Class IIITerminatedMar 11, 2015Oxecta(TM)Failed Impurities/Degradation SpecificationsPfizer Inc. · D-0404-2015Class IIITerminatedMar 11, 2015Oxecta(TM)Failed Impurities/Degradation SpecificationsPfizer Inc. · D-0403-2015Class IIITerminatedMar 11, 2015Quinapril Tablets USPSubpotent DrugAVKARE Inc. · D-0402-2015Class IIITerminatedMar 11, 2015Quinapril Tablets USPSubpotent DrugAVKARE Inc. · D-0401-2015Class IIITerminatedMar 11, 2015Z-COTE HP 1 TRANSPARENT ZINC OXIDELabeling: Illegible label. Writing is rubbing off of labels.Nanophase Technologies Corporation · D-0400-2015Class IITerminatedMar 11, 2015Atracurium Besylate InjectionLack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product...Sagent Pharmaceuticals Inc · D-0399-2015Class IITerminatedMar 11, 2015Atracurium Besylate InjectionLack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product...Sagent Pharmaceuticals Inc · D-0398-2015Class IITerminatedMar 11, 2015AMLODIPINE BESYLATE TABLETS USPFailed tablet specifications: One lot was found to contain oversized tablets.Qualitest Pharmaceuticals · D-0397-2015Class IITerminatedMar 11, 2015Vancomycin Hydrochloride CapsulesSubpotent DrugActavis Inc · D-0396-2015Class IITerminatedMar 11, 2015Dextroamphetamine Sulfate Extended-Release CapsulesFailed Dissolution SpecificationsActavis Elizabeth LLC · D-0395-2015Class IITerminatedMar 4, 2015Ketorolac Tromethamine Ophthalmic SolutionPresence of Particulate Matter: lot is not meeting the specification limit for number of particles present in the solution.Sun Pharma Global Fze · D-0394-2015Class IITerminatedMar 4, 2015Mafenide AcetatePresence of Foreign Substance; oxidized steel, organic material and shredded polypropylenePar Pharmaceutical Inc. · D-0393-2015Class ITerminatedFeb 25, 2015LACTATED RINGER'S and 5% DEXTROSE Injection USPNon-Sterility: Confirmed customer complaint of particulate matter floating within the solution of the primary container, consistent with mold.Hospira Inc. · D-0392-2015Class ITerminatedFeb 25, 20151% LIDOCAINE HCl InjectionPresence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.Hospira Inc. · D-0391-2015Class IITerminatedFeb 25, 2015Vancomycin Hydrochloride for InjectionTemperature Abuse: Products experienced uncontrolled temperature excursions during transit.Hospira Inc. · D-0390-2015Class ITerminatedFeb 25, 2015Propofol Injectable EmulsionTemperature Abuse: Products experienced uncontrolled temperature excursions during transit.Hospira Inc. · D-0389-2015Class IITerminatedFeb 25, 2015Ketorolac Tromethamine InjTemperature Abuse: Products experienced uncontrolled temperature excursions during transit.Hospira Inc. · D-0388-2015Class IITerminatedFeb 25, 2015Vancomycin Hydrochloride for InjectionTemperature Abuse: Products experienced uncontrolled temperature excursions during transit.Hospira Inc. · D-0387-2015Class IITerminatedFeb 18, 2015Compounded PlaquexGood Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.AnazaoHealth Corporation · D0384-2015Class IITerminatedFeb 18, 2015LevetiracetamFailed Dissolution Specifications: 6 month time point.Sun Pharma Global Fze · D-0386-2015Class IITerminatedFeb 18, 2015Erythromycin Pledgets USPMicrobial Contamination of Non-Sterile Products: Active Pharmaceutical Ingredient (API) failed USP microbial tests.Akorn, Inc. · D-0385-2015Class IITerminatedFeb 11, 2015Children's Loratadine SyrupPresence of Foreign Substance: Presence of blue plastic floating in loratadine syrup.Taro Pharmaceuticals U.S.A., Inc. · D-0383-2015